News

September 22, 2017September 22, 2017

Veracyte, LCI Aim to Raise Awareness in N.C. About Early Lung Cancer Screening

Lung Cancer, News

In partnership with the Lung Cancer Initiative (LCI), Veracyte has launched an awareness-raising campaign to increase screening for lung cancer among high-risk populations in North Carolina. The campaign, “Screen Together,” was created to ... Read more

September 21, 2017September 21, 2017

IPF World Week 2017: Listening for the Sounds of IPF May Lead to Earlier Diagnosis

Idiopathic Pulmonary Fibrosis, News

Recognizing how difficult it is to diagnose idiopathic pulmonary fibrosis, Boehringer Ingelheim has created a detection system based on sounds coming from the lungs. Because the sounds of people with the disease ... Read more

September 20, 2017September 20, 2017

FibroGen’s Pamrevlumab Slows Lung Function Decline in IPF Patients, Trial Results Show

Idiopathic Pulmonary Fibrosis, News

Lung function decline in patients with idiopathic pulmonary fibrosis (IPF) was slowed by the investigational drug pamrevlumab, according to the results from a Phase 2b clinical trial. The results were presented ... Read more

September 19, 2017September 19, 2017

Tezepelumab Reduces Exacerbation Rates in Patients with Severe Asthma, Trial Results Show

Asthma, News

Patients with severe and uncontrolled asthma who took tezepelumab had significantly lower annual asthma exacerbation rates than those on placebo, according to the latest results of the PATHWAY Phase 2b trial. ... Read more

September 18, 2017September 18, 2017

AstraZeneca’s Tagrisso a Potential New Standard of Care in EGFR-mutated Lung Cancer

Lung Cancer, News

Results of a Phase 3 trial support the use of Tagrisso (osimertinib) as a new standard of care in the first-line treatment of patients with epidermal growth factor receptor-mutated (EGFRm) ... Read more

September 15, 2017September 15, 2017

Identification of Regenerative and Scar-Forming Cells May Lead to New Lung Therapies, Study Reports

COPD, Idiopathic Pulmonary Fibrosis, News

Researchers have identified two types of lung cells, one with regenerative features and the other with scar-forming characteristics, according to a study published in the journal Cell. The research team ... Read more

September 14, 2017September 14, 2017

Synairgen and Pharmaxis’ Fibrosis Therapy Candidate Is Heading for Phase 1 Clinical Trial

Idiopathic Pulmonary Fibrosis, News

A potential pulmonary fibrosis therapy that Synairgen and Pharmaxis have been working on is heading for a Phase 1 clinical trial. The two created PXS-5382A as a treatment for idiopathic pulmonary fibrosis (IPF) and other ... Read more

September 13, 2017September 13, 2017

INJOURNEY Trial Data Shows Ofev-Esbriet Combo Is Safe and IPF Patients Tolerate It Well

Idiopathic Pulmonary Fibrosis, News

A combination of Boehringer Ingelheim‘s Ofev (nintedanib) and Genentech’s Esbriet (pirfenidone) as a treatment for idiopathic pulmonary fibrosis (IPF) was safe and well tolerated, according to the latest data from the Phase 4 INJOURNEY trial. ... Read more

September 12, 2017September 12, 2017

Inventiva Announces Further Collaboration with Boehringer Ingelheim to Develop IPF Therapies

Idiopathic Pulmonary Fibrosis, News

Inventiva Pharma recently announced that Boehringer Ingelheim will extend a collaboration with the company to further advance potential treatments for fibrotic conditions including idiopathic pulmonary fibrosis (IPF). The collaboration began in May 2016 as a research and ... Read more

September 11, 2017September 11, 2017

Study Links Fungus Antibodies with Development of Bronchiectasis in COPD Patients

Bronchiectasis, COPD, News

Researchers have linked the presence of antibodies against the Aspergillus fumigatus (A fum) fungus with the development of bronchiectasis in people with COPD. The study, “Sensitization to Aspergillus fumigatus as a risk factor ... Read more